Financials
- Market Capitalization 55.03 M
- Employee 21
- Founded 2015
- CEO N/A
- Website www.inmunebio.com
- Headquarter Nevada, United States
- FIGI BBG00LW94L98
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.69
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4242 | BOLD Boundless Bio, Inc. - Common Stock | 2.47 USD | +0.41% | -0.80% | +72.73% | +112.93% | 55.49 M USD | ||
| 4246 | INKT MiNK Therapeutics, Inc. - Common Stock | 11.09 USD | -2.80% | +5.82% | -11.70% | +0.82% | 55.25 M USD | ||
| 4265 | XLO Xilio Therapeutics, Inc. - Common Stock | 9.12 USD | +1.00% | -1.30% | +9.75% | +1149.32% | 52.74 M USD | ||
| 4266 | MREO Mereo BioPharma Group plc - American Depositary Shares | 0.33 USD | +6.45% | +6.45% | +10.00% | -81.25% | 52.67 M USD |